JAZZ vs MITQ · P/E 1988, rev $2.28B vs rev $12.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Moving iMage Technologies Inc (MITQ) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Moving iMage Technologies Inc (MITQ) is a communication equipment company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MITQ revenue for 2026-03-31 was $12.8M. Net income was -$1.0K. Revenue was up 36.2% from 2025-12-31 to 2026-03-31. MITQ currently screens at market cap $7.2M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MITQ currently screens at market cap $7.2M.
Not investment advice. Open the JAZZ and MITQ stock pages for the full models.
Not investment advice.